FDA-Drug2026-02-18Class IIPACKAGING DEFECT
Meitheal Cetrorelix Acetate injection kit recalled for missing or duplicated needles
What this means
Meitheal Pharmaceuticals is recalling Cetrorelix Acetate 0.25 mg injection kits because some contain missing or duplicated needles in the delivery system. This affects lot Q4E0112A with an expiration date of April 30, 2027. The defect could prevent proper injection or cause unsafe handling.
- Check if you have lot Q4E0112A (expiration April 30, 2027)
- Stop using affected kits immediately
- Contact your pharmacy or healthcare provider for a replacement
- Do not attempt to use a kit with missing or extra needles
The agency's original wording
Hazard
Defective Delivery System: Missing or duplicated needles within the injection kit
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide
Affected count
16,477 kits
Manufactured in
8700 W Bryn Mawr Ave Ste 600s, N/A, Chicago, IL, United States
Products
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0340-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.